Sensei Biotherapeutics regains Nasdaq minimum bid price compliance

Sensei Biotherapeutics, Inc.

Received Nasdaq letter on July 2, 2025 confirming compliance with Rule 5550(a)(2).
Closing bid price was at or above $1.00 for 10 consecutive business days (June 17 to July 1, 2025).
No further action required; delisting risk removed.

item 3.01

Source: SEC EDGAR

accession 0001193125-25-157113

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.